NDC 59051-9128 - ThyroKare
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59051-9128
- Package NDCs from labels
- 59051-9128-9
- Manufacturer
- Neogen Corporation-Mercer Rd | Peptido GmbH
- Effective date
- 2018-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ThyroKare - Neogen Corporation-Mercer Rd | Peptido GmbH | Neogen Corporation-Mercer Rd | Peptido GmbH | 2018-11-01 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59051-9128-9 | ThyroKare | 4536 g in 1 PAIL | Powder | 4536 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59051-9128 | THYROKARE (LEVOTHYROXINE SODIUM) POWDER [NEOGEN CORPORATION-MERCER RD] | 1 | 1 package rows | 20181102_f200780c-8532-43e3-bc97-c901ebddb1da.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 50b1c8a4-75b6-49c8-80fc-3841ee80b183 | 2020-12-04 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 12ccf2fd-ccf0-4bcf-8eee-e2a16c8b44d6 | 2020-12-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 97e28b00-9913-463f-9de2-08c828edbe67 | 2020-03-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 05ab038e-45fa-488e-a05e-12a2dd3564c1 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | b81720f9-2836-4c1d-8691-0f6acef13316 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 3019762c-d480-4530-a3b2-762b523e7961 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 434075d5-a82b-4f17-85e6-4c1922663dbc | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 18c7c63a-642e-47fe-a8ee-12aaf652b2aa | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Unithroid | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals LLC | 07562e72-7eaa-4ce6-94f0-e08814787e50 | 2019-06-19 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.